Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jeffrey, Damrauer"'
Autor:
Damrauer, Jeffrey S.1 (AUTHOR), Smith, Markia A.2 (AUTHOR), Walter, Vonn3 (AUTHOR), Thennavan, Aatish4 (AUTHOR), Mose, Lisle E.1 (AUTHOR), Selitsky, Sara R.1,5,6 (AUTHOR), Hoadley, Katherine A.1,5,6 (AUTHOR) hoadley@med.unc.edu
Publikováno v:
Communications Biology. 10/4/2021, Vol. 4 Issue 1, p1-13. 13p.
Autor:
Swarnali, Acharyya, Katherine J, Ladner, Lori L, Nelsen, Jeffrey, Damrauer, Peter J, Reiser, Steven, Swoap, Denis C, Guttridge
Publikováno v:
Journal of Clinical Investigation. 114:370-378
Cachexia is a syndrome characterized by wasting of skeletal muscle and contributes to nearly one-third of all cancer deaths. Cytokines and tumor factors mediate wasting by suppressing muscle gene products, but exactly which products are targeted by t
Publikováno v:
Cancers. Feb2023, Vol. 15 Issue 3, p631. 112p.
Publikováno v:
Cancer (0008543X); 12/15/2023, Vol. 129 Issue 24, p3989-3995, 7p
Publikováno v:
Cancer (0008543X); 12/15/2022, Vol. 128 Issue 24, p4296-4302, 7p
Autor:
Jeffrey S. Damrauer, Markia A. Smith, Vonn Walter, Aatish Thennavan, Lisle E. Mose, Sara R. Selitsky, Katherine A. Hoadley
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Jeffrey Damrauer, Markia Smith et al. used existing datasets from cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC) to characterize two subsets of HCC distinct from prototypical HCC tumors, based on comprehensive analysis of molecular data.
Externí odkaz:
https://doaj.org/article/c7c5f92165e344fcb51842120c0bf9d1
Publikováno v:
Cancer Biology and Therapy; November 2004, Vol. 3 Issue: 11 p1039-1044, 6p
Autor:
Markia A. Smith, Jeffrey S. Damrauer, Lisle E. Mose, Sara R. Selitsky, Aatish Thennavan, Vonn Walter, Katherine A. Hoadley
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Communications Biology
Communications Biology
Primary liver cancer, consisting of both cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC), is the second leading cause of cancer deaths worldwide. Our goal is to genomically characterize rare HCC subclasses to provide insight into disease
Autor:
Jeffrey S. Damrauer, James V. Alvarez
Publikováno v:
Cancer Research. 78:PR09-PR09
Tumor progression is the process by which cancer cells acquire increasingly aggressive characteristics, including resistance to therapies and an increased propensity to metastasize. The combination of these two processes results in recurrence of tumo
Publikováno v:
Cancer Biology & Therapy; Nov2004, Vol. 3 Issue 11, p1042-1043, 2p